Drug Free Solution Stock Analysis
| DSOL Stock | USD 0 0.00 0.00% |
Drug Free's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Drug Free's financial risk is the risk to Drug Free stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Drug Free's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Drug Free is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Drug Free to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Drug Free is said to be less leveraged. If creditors hold a majority of Drug Free's assets, the Company is said to be highly leveraged.
Drug Free Solution is overvalued with Real Value of 0.001153 and Hype Value of 0.001592. The main objective of Drug Free pink sheet analysis is to determine its intrinsic value, which is an estimate of what Drug Free Solution is worth, separate from its market price. There are two main types of Drug Free's stock analysis: fundamental analysis and technical analysis.
The Drug Free pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Drug |
Drug Pink Sheet Analysis Notes
The company recorded a loss per share of 0.01. Drug Free Solution had not issued any dividends in recent years. The entity had 3:1 split on the 9th of January 2014. Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. The company was formerly known as Living Breath Project, Inc. and changed its name to Drug Free Solution, Inc. in January 2014. DRUG FREE is traded on PNK Exchange in the United States.The quote for Drug Free Solution is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Drug Free Solution call the company at 888-615-6122 or check out https://www.drugfreesolution.com.Drug Free Solution Investment Alerts
| Drug Free Solution has some characteristics of a very speculative penny stock | |
| Drug Free Solution had very high historical volatility over the last 90 days | |
| The company has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Drug Free until it has trouble settling it off, either with new capital or with free cash flow. So, Drug Free's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Drug Free Solution sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Drug to invest in growth at high rates of return. When we think about Drug Free's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (755.87 K) with loss before overhead, payroll, taxes, and interest of (171.22 K). | |
| Drug Free Solution currently holds about 7.12 K in cash with (692.31 K) of positive cash flow from operations. |
Drug Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 503.2 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Drug Free's market, we take the total number of its shares issued and multiply it by Drug Free's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 9th of February, Drug Free shows the Mean Deviation of 0.8139, standard deviation of 3.36, and Variance of 11.27. Drug Free Solution technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Drug Free Solution market risk adjusted performance and total risk alpha to decide if Drug Free Solution is priced favorably, providing market reflects its regular price of 0.0014 per share. As Drug Free Solution appears to be a penny stock we also advise to verify its information ratio numbers.Drug Free Solution Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Drug Free price series with the more recent values given greater weights.
Drug Free Outstanding Bonds
Drug Free issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Drug Free Solution uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Drug bonds can be classified according to their maturity, which is the date when Drug Free Solution has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Drug Free Predictive Daily Indicators
Drug Free intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Drug Free pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0014 | |||
| Day Typical Price | 0.0014 |
Drug Free Forecast Models
Drug Free's time-series forecasting models are one of many Drug Free's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Drug Free's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Drug Free Solution Debt to Cash Allocation
Many companies such as Drug Free, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
The company has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Drug Free until it has trouble settling it off, either with new capital or with free cash flow. So, Drug Free's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Drug Free Solution sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Drug to invest in growth at high rates of return. When we think about Drug Free's use of debt, we should always consider it together with cash and equity.Drug Free Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Drug Free's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Drug Free, which in turn will lower the firm's financial flexibility.Drug Free Corporate Bonds Issued
About Drug Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Drug Free prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Drug shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Drug Free. By using and applying Drug Pink Sheet analysis, traders can create a robust methodology for identifying Drug entry and exit points for their positions.
Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. The company was formerly known as Living Breath Project, Inc. and changed its name to Drug Free Solution, Inc. in January 2014. DRUG FREE is traded on PNK Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Drug Free to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Other Information on Investing in Drug Pink Sheet
Drug Free financial ratios help investors to determine whether Drug Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Drug with respect to the benefits of owning Drug Free security.